Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Clin Ter ; 174(4): 336-342, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37378503

RESUMEN

Background: Mesotherapy is a technique through which active ingredients are administered into the thickness of the skin in order to increase the local analgesic effect. Methods: 141 patients with spinal pain not responding to systemic therapy with NSAIDs were randomized to receive one or more intra-cutaneous drugs on a weekly basis. Results: All patients achieved a pain reduction of at least 50% compared to baseline, and all tolerated the therapy without having to resort to systemic drug dose increases. Conclusions: The data from our study show that the active ingredients infiltrated into the skin induce a mesodermal modulation between the infiltrated liquid and the cutaneous nervous and cellular structures from which the typical drug-saving effect of mesotherapy arises. Although further studies are needed to establish how to integrate mesotherapy in various clinical settings, it appears to be a useful technique available to the practicing physician. This research is also useful in guiding future clinical research.


Asunto(s)
Mesoterapia , Humanos , Mesoterapia/métodos , Antiinflamatorios no Esteroideos/uso terapéutico , Dolor/tratamiento farmacológico
2.
Biomed Pharmacother ; 156: 113844, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36252359

RESUMEN

The 2-pentadecyl-2-oxazoline (PEA-OXA) is a natural compound with protective action in neuro-inflammation. We have previously shown that PEA-OXA behaves as an α2 adrenergic receptor (α2AR) antagonist and a putative protean agonist on histamine H3 receptors. Recently, neuroinflammation and monoaminergic neurotransmission dysfunction has drawn particular attention in Alzheimer Disease (AD) pathophysiology. In this context, the objective of this study was to investigate the effects of the dual-acting PEA-OXA in an AD-like model in mice. A combined computational and experimental approach was used to evaluate the ability of PEA-OXA to bind α2A-AR subtype, and to investigate the effects of PEA-OXA treatment on neuropathological (behavioural and functional) effects induced by soluble Amyloid ß 1-42 (sAß1-42) intracerebroventricular injection. Computational analysis revealed the PEA-OXA ability to bind the α2A-AR, a pharmacological target for AD, in two alternative poses, one overlapping the Na+ binding site. In vivo studies indicated that chronic treatment with PEA-OXA (10 mg/kg, os) restored the cognitive (discriminative and spatial memory) deficits and social impairments induced by sAß injection. Consistently, electrophysiological analysis showed a recovery of the long-term potentiation in the hippocampus (Lateral Entorhinal Cortex-Dentate Gyrus pathway), while neuroinflammation, i.e., increased pro-inflammatory cytokines levels and microglia cells density were reduced. These data provide the basis for further investigation of the pro-cognitive aptitude of PEA-OXA by proposing it as an adjuvant in the treatment in AD, for which the available pharmacological approaches remain unsatisfactory. Moreover, this study offers new future direction in research investigating the role of α2AR in neuropsychiatric illness and therapies.


Asunto(s)
Enfermedad de Alzheimer , Péptidos beta-Amiloides , Ratones , Animales , Péptidos beta-Amiloides/toxicidad , Péptidos beta-Amiloides/metabolismo , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/prevención & control , Receptores Adrenérgicos alfa 2 , Modelos Animales de Enfermedad , Conducta Social , Cognición
3.
Biomed Pharmacother ; 153: 113488, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-36076584

RESUMEN

Up to 80 % nursing home residents with dementia experiences chronic pain. Contextually, 97 % presents fluctuant neuropsychiatric symptoms (NPS). Among the most challenging is agitation, connected with undertreated pain and managed through neuroleptics doubling death risk. Evidence is accumulating in favor of the involvement of the endocannabinoid system in nociception and NPS. This double-blind, placebo-controlled, randomized trial (NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia [NACTOPAISD]) aims at investigating efficacy and safety of oral spray nabiximols, containing Δ9-tetrahydrocannabinol and cannabidiol (Sativex®), for pain and agitation treatment in severe dementia patients (Mini-Mental State Examination ≤ 12) over 65. The coprimary endpoints are efficacy on pain and agitation, assessed through the recently validated Italian Mobilization-Observation-Behavior-Intensity-Dementia and the Cohen-Mansfield Agitation Inventory. The secondary endpoint is the evaluation of efficacy duration after wash-out and the assessment of quality of life through the DEMQOL. Any adverse events will be reported. The results undergo statistical analysis plan. NACTOPAISD might provide rationale for a translational safer pain and agitation treatment in severe dementia. It is approved by Calabria Region Ethics Committee and follows the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) and the Consolidated Standards of Reporting Trials (CONSORT) statements.


Asunto(s)
Cannabidiol , Dolor Crónico , Demencia , Dronabinol , Agitación Psicomotora , Anciano , Cannabidiol/administración & dosificación , Cannabidiol/efectos adversos , Dolor Crónico/tratamiento farmacológico , Dolor Crónico/etiología , Demencia/complicaciones , Demencia/tratamiento farmacológico , Método Doble Ciego , Dronabinol/administración & dosificación , Dronabinol/efectos adversos , Combinación de Medicamentos , Humanos , Vaporizadores Orales , Agitación Psicomotora/tratamiento farmacológico , Agitación Psicomotora/etiología , Ensayos Clínicos Controlados Aleatorios como Asunto
4.
Brain Res Bull ; 174: 323-338, 2021 09.
Artículo en Inglés | MEDLINE | ID: mdl-34192579

RESUMEN

The prelimbic division (PrL) of the medial prefrontal cortex (mPFC) is a cerebral division that is putatively implicated in the chronic pain and depression. We investigated the activity of PrL cortex neurons in Wistar rats that underwent chronic constriction injury (CCI) of sciatic nerve and were further subjected to the forced swimming (FS) test and mechanical allodynia (by von Frey test). The effect of blockade of synapses with cobalt chloride (CoCl2), and the treatment of the PrL cortex with cannabidiol (CBD), the CB1 receptor antagonist AM251 and the 5-HT1A receptor antagonist WAY-100635 were also investigated. Our results showed that CoCl2 decreased the time spent immobile during the FS test but did not alter mechanical allodynia. CBD (at 15, 30 and 60 nmol) in the PrL cortex also decreased the frequency and duration of immobility; however, only the dose of 30 nmol of CBD attenuated mechanical allodynia in rats with chronic NP. AM251 and WAY-100635 in the PrL cortex attenuated the antidepressive and analgesic effect caused by CBD but did not alter the immobility and the mechanical allodynia when administered alone. These data show that the PrL cortex is part of the neural substrate underlying the comorbidity between NP and depression. Also, the previous blockade of CB1 cannabinoid receptors and 5-HT1A serotonergic receptors in the PrL cortex attenuated the antidepressive and analgesics effect of the CBD. They also suggest that CBD could be a potential medicine for the treatment of depressive and pain symptoms in patients with chronic NP/depression comorbidity.


Asunto(s)
Cannabidiol/farmacología , Depresión/tratamiento farmacológico , Neuralgia/tratamiento farmacológico , Corteza Prefrontal/efectos de los fármacos , Receptor Cannabinoide CB1/agonistas , Receptor de Serotonina 5-HT1A/efectos de los fármacos , Animales , Cannabidiol/administración & dosificación , Enfermedad Crónica , Cobalto , Depresión/complicaciones , Sistema Límbico , Microinyecciones , Neuralgia/complicaciones , Piperazinas/uso terapéutico , Piperidinas/farmacología , Pirazoles/farmacología , Piridinas/uso terapéutico , Ratas , Ratas Wistar , Ciática/tratamiento farmacológico , Ciática/patología , Antagonistas del Receptor de Serotonina 5-HT1/uso terapéutico , Natación/psicología , Sinapsis/efectos de los fármacos
5.
Brain Behav Immun ; 67: 230-245, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28890155

RESUMEN

The microbiota-gut-brain axis (MGBA) regulates the reciprocal interaction between chronic inflammatory bowel and psychiatric disorders. This interaction involves multiple pathways that are highly debated. We examined the behavioural, biochemical and electrophysiological alterations, as well as gut microbiota composition in a model of antibiotic-induced experimental dysbiosis. Inflammation of the small intestine was also assessed. Mice were exposed to a mixture of antimicrobials for 2weeks. Afterwards, they received Lactobacillus casei DG (LCDG) or a vehicle for up to 7days via oral gavage. Perturbation of microbiota was accompanied by a general inflammatory state and alteration of some endocannabinoidome members in the gut. Behavioural changes, including increased immobility in the tail suspension test and reduced social recognition were observed, and were associated with altered BDNF/TrkB signalling, TRPV1 phosphorylation and neuronal firing in the hippocampus. Moreover, morphological rearrangements of non-neuronal cells in brain areas controlling emotional behaviour were detected. Subsequent probiotic administration, compared with vehicle, counteracted most of these gut inflammatory, behavioural, biochemical and functional alterations. Interestingly, levels of Lachnospiraceae were found to significantly correlate with the behavioural changes observed in dysbiotic mice. Our findings clarify some of the biomolecular and functional modifications leading to the development of affective disorders associated with gut microbiota alterations.


Asunto(s)
Antibacterianos/administración & dosificación , Depresión/microbiología , Endocannabinoides/metabolismo , Microbioma Gastrointestinal/efectos de los fármacos , Hipocampo/metabolismo , Inflamación/microbiología , Neuroglía/metabolismo , Animales , Conducta Animal/efectos de los fármacos , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Depresión/metabolismo , Disbiosis/complicaciones , Disbiosis/metabolismo , Disbiosis/microbiología , Hipocampo/efectos de los fármacos , Inflamación/complicaciones , Inflamación/metabolismo , Mucosa Intestinal/metabolismo , Intestinos/efectos de los fármacos , Intestinos/microbiología , Masculino , Ratones Endogámicos C57BL , Neuroglía/efectos de los fármacos , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Probióticos/administración & dosificación
6.
Sci Rep ; 7(1): 375, 2017 03 23.
Artículo en Inglés | MEDLINE | ID: mdl-28336953

RESUMEN

The endogenous fatty acid amide palmitoylethanolamide (PEA) has been shown to exert anti-inflammatory actions mainly through inhibition of the release of pro-inflammatory molecules from mast cells, monocytes and macrophages. Indirect activation of the endocannabinoid (eCB) system is among the several mechanisms of action that have been proposed to underlie the different effects of PEA in vivo. In this study, we used cultured rat microglia and human macrophages to evaluate whether PEA affects eCB signaling. PEA was found to increase CB2 mRNA and protein expression through peroxisome proliferator-activated receptor-α (PPAR-α) activation. This novel gene regulation mechanism was demonstrated through: (i) pharmacological PPAR-α manipulation, (ii) PPAR-α mRNA silencing, (iii) chromatin immunoprecipitation. Moreover, exposure to PEA induced morphological changes associated with a reactive microglial phenotype, including increased phagocytosis and migratory activity. Our findings suggest indirect regulation of microglial CB2R expression as a new possible mechanism underlying the effects of PEA. PEA can be explored as a useful tool for preventing/treating the symptoms associated with neuroinflammation in CNS disorders.


Asunto(s)
Movimiento Celular/efectos de los fármacos , Etanolaminas/farmacología , Macrófagos/efectos de los fármacos , Microglía/efectos de los fármacos , Ácidos Palmíticos/farmacología , Fagocitosis/efectos de los fármacos , Receptor Cannabinoide CB2/metabolismo , Amidas , Animales , Células HEK293 , Humanos , Macrófagos/metabolismo , Microglía/metabolismo , PPAR alfa/metabolismo , ARN Mensajero/metabolismo , Ratas
7.
Mol Brain ; 8: 47, 2015 Aug 12.
Artículo en Inglés | MEDLINE | ID: mdl-26260027

RESUMEN

BACKGROUND: Enhanced supraspinal glutamate levels following nerve injury are associated with pathophysiological mechanisms responsible for neuropathic pain. Chronic pain can interfere with specific brain areas involved in glutamate-dependent neuropsychological processes, such as cognition, memory, and decision-making. The medial prefrontal cortex (mPFC) is thought to play a critical role in pain-related depression and anxiety, which are frequent co-morbidities of chronic pain. Using an animal model of spared nerve injury (SNI) of the sciatic nerve, we assess bio-molecular modifications in glutamatergic synapses in the mPFC that underlie neuropathic pain-induced plastic changes at 30 days post-surgery. Moreover, we examine the effects of palmitoylethanolamide (PEA) administration on pain-related behaviours, as well as the cortical biochemical and morphological changes that occur in SNI animals. RESULTS: At 1 month, SNI was associated with mechanical and thermal hypersensitivity, as well as depression-like behaviour, cognitive impairments, and obsessive-compulsive activities. Moreover, we observed an overall glutamate synapse modification in the mPFC, characterized by changes in synaptic density proteins and amino acid levels. Finally, with regard to the resolution of pain and depressive-like syndrome in SNI mice, PEA restored the glutamatergic synapse proteins and changes in amino acid release. CONCLUSIONS: Given the potential role of the mPFC in pain mechanisms, our findings may provide novel insights into neuropathic pain forebrain processes and indicate PEA as a new pharmacological tool to treat neuropathic pain and the related negative affective states. Graphical Abstract Palmitoylethanolamide: a new pharmacological tool to treat neuropathic pain and the related negative affective states.


Asunto(s)
Conducta Animal/efectos de los fármacos , Etanolaminas/uso terapéutico , Ácido Glutámico/metabolismo , Homeostasis/efectos de los fármacos , Neuralgia/tratamiento farmacológico , Ácidos Palmíticos/uso terapéutico , Corteza Prefrontal/metabolismo , Sinapsis/metabolismo , Amidas , Animales , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Células Cultivadas , Fenómenos Electrofisiológicos/efectos de los fármacos , Etanolaminas/farmacología , Inmovilización , Masculino , Ratones , Microglía/efectos de los fármacos , Microglía/metabolismo , Microinyecciones , Neuralgia/metabolismo , Neuralgia/patología , Neuralgia/fisiopatología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Ácidos Palmíticos/farmacología , Corteza Prefrontal/efectos de los fármacos , Corteza Prefrontal/patología , Corteza Prefrontal/fisiopatología , Proteínas Proto-Oncogénicas c-akt/metabolismo , Receptor trkB/metabolismo , Transducción de Señal/efectos de los fármacos , Sinapsis/efectos de los fármacos , Cola (estructura animal)
8.
Pharmacol Res ; 91: 36-46, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25434589

RESUMEN

Peripheral neuropathy is characterized by abnormal pain responses triggered by the release of several mediators and neuronal hyperexcitability at the spinal cord level. Emerging evidence indicates that the enhanced activity of dorsal horn neurons requires communication with glia and microglia, cells that are physiologically involved in neuronal wellbeing. Prokineticins (PKs), which include PK1 and PK2, represent a novel family of chemokines characterized by a unique structural motif comprising five disulfide bonds. They are expressed in the peripheral and central nervous system. PKs bind two G protein coupled receptors, PKR1 and PKR2, and participate in the regulation of several biological processes, including pain sensation. This study aimed to investigate the anti-nociceptive effect of PC1, a non-peptide PKR1-preferring antagonist, in a mouse model of neuropathic pain. To do this, we assessed the activity of spinal cord nociceptive neurons as well as astrocyte and microglia phenotypes after repeated administration of PC1 in vivo. PC1 treatment strongly delayed the development of thermal hyperalgesia and tactile and mechanical allodynia. It also reduced spinal microglial and glial activation 8 days post injury in spared nerve injury (SNI) mice. Neuropathic mice showed an increased level of PK2 protein in the spinal cord, mostly in astrocytes. PC1 treatment completely reversed the increased responsiveness to mechanical stimuli, the decreased threshold of neuronal activation, and the increased spontaneous activity that were observed in nociceptive specific (NS) neurons of SNI mice.


Asunto(s)
Analgésicos/uso terapéutico , Hormonas Gastrointestinales/metabolismo , Neuralgia/tratamiento farmacológico , Neuropéptidos/metabolismo , Receptores Acoplados a Proteínas G/antagonistas & inhibidores , Médula Espinal/efectos de los fármacos , Triazinas/uso terapéutico , Animales , Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Conducta Animal/efectos de los fármacos , Hormonas Gastrointestinales/genética , Calor , Hiperalgesia/tratamiento farmacológico , Hiperalgesia/metabolismo , Masculino , Ratones , Neuralgia/metabolismo , Neuronas/efectos de los fármacos , Neuronas/fisiología , Neuropéptidos/genética , Traumatismos de los Nervios Periféricos/tratamiento farmacológico , Traumatismos de los Nervios Periféricos/metabolismo , ARN Mensajero/metabolismo , Receptores Acoplados a Proteínas G/genética , Receptores Acoplados a Proteínas G/metabolismo , Nervio Ciático/efectos de los fármacos , Nervio Ciático/lesiones , Nervio Ciático/metabolismo , Médula Espinal/metabolismo , Médula Espinal/fisiología , Triazinas/farmacología
9.
Plant Dis ; 99(1): 155, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30699767

RESUMEN

European hackberry (Celtis australis L.) is a popular shade tree mainly planted in southern Europe and known to be tolerant to dry and poor soils. In early autumn 2013, hackberry plants grown in soil in a commercial nursery located in the floodplain in Umbria region showed symptoms of wilting, dieback, and death. Up to 100% of the canopy was affected, and over 60% of the plants were symptomatic or dead. A Phytophthora species was consistently isolated from symptomatic 6-year-old plants by plating small pieces of collar and root tissues, cut from the margin of dark-brown necrotic lesions, onto P5ARPH selective medium (4). Pure cultures were obtained by single-hyphal transfers on potato dextrose agar (PDA). Sporangia, produced on pepper seeds in soil extract solution (3), were nonpapillate and noncaducous, measuring 34.0 to 85.0 × 22.0 to 50.0 µm. Oospores had an average diameter of 44 µm with mostly paragynous antheridia. On the basis of morphological features, the isolates were identified as P. megasperma Drech. (2). The identity was confirmed by sequencing the cytochrome c oxidase subunit II (Cox II) (5), which gave 100% identity with P. megasperma sequences available in GenBank (GU222070), and by sequencing the internal transcribed spacer (ITS) using the universal primers ITS4 and ITS6, which gave 99% identity with the AF266794 sequence from Cooke et al. (1). The sequences of one isolate (AB239) were deposited in the European Nucleotide Archive (ENA) with accession numbers HG973451 and HG973450 for Cox II and ITS, respectively. Pathogenicity tests were conducted in the greenhouse with isolate AB239 on eight 2-year-old potted European hackberry plants. Mycelial plugs (5 mm diameter) cut from the margins of actively growing 8-day-old cultures on PDA were inserted through the epidermis to the phloem at the collar level. Two plants were used as controls and treated as described above except that sterile PDA plugs replaced the inoculum. Inoculated plants were kept for 4 weeks in a greenhouse at 24 ± 2°C. During that period, inoculated plants showed wilting symptoms similar to those observed in the field. Lesions were evident at all the inoculation points progressing downward to the roots. Colonies of Phytophthora were isolated from the margins of lesions and identified as P. megasperma, thus fulfilling Koch's postulates. Controls remained symptomless. P. megasperma taxonomy is rather complex since it embraces different subgroups, including host specialized forms (formae speciales), some of which are recognized as biological species. Based on morphological and molecular data presented here, the Phytophthora isolates from hackberry belong to P. megasperma sensu stricto, which is included in the "pathogenic to a broad range of hosts" (BHR) group (1). This pathogen is rather polyphagous, attacking mainly fruit and ornamental woody plants, commonly Prunus spp., Malus spp., and Actinidia deliciosa. Like other homothallic Phytophthora species, it is particularly dangerous due to its abundant production of thick-walled resting oospores that enable long-term survival in the soil. To our knowledge this is the first report of P. megasperma sensu stricto (1) on C. australis and its family Ulmaceae/Cannabaceae. References: (1) D. E. L. Cooke et al. Fungal Genet. Biol. 30:17, 2000. (2) D. C. Erwin and O. K. Ribeiro, American Phytopathological Society, St. Paul, MN, 1996. (3) E. Ilieva et al. Eur. J. Plant Path. 101:623, 1995. (4) S. N. Jeffers and S. B. Martin. Plant Dis. 70:1038, 1986. (5) F. N. Martin and P. W. Tooley. Mycologia 95:269, 2003.

10.
Br J Pharmacol ; 171(21): 4850-65, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24902717

RESUMEN

BACKGROUND AND PURPOSE: Chemokines are involved in neuroinflammation and contribute to chronic pain processing. The new chemokine prokineticin 2 (PROK2) and its receptors (PKR1 and PKR2 ) have a role in inflammatory pain and immunomodulation. In the present study, we investigated the involvement of PROK2 and its receptors in neuropathic pain. EXPERIMENTAL APPROACH: Effects of single, intrathecal, perineural and s.c. injections of the PKR antagonist PC1, or of 1 week s.c. treatment, on thermal hyperalgesia and tactile allodynia was evaluated in mice with chronic constriction of the sciatic nerve (CCI). Expression and localization of PROK2 and of its receptors at peripheral and central level was evaluated 10 days after CCI, following treatment for 1 week with saline or PC1. IL-1ß and IL-10 levels, along with glia activation, were evaluated. KEY RESULTS: Subcutaneous, intrathecal and perineural PC1 acutely abolished the CCI-induced hyperalgesia and allodynia. At 10 days after CCI, PROK2 and its receptor PKR2 were up-regulated in nociceptors, in Schwann cells and in activated astrocytes of the spinal cord. Therapeutic treatment with PC1 (s.c., 1 week) alleviated established thermal hyperalgesia and allodynia, reduced the injury-induced overexpression of PROK2, significantly blunted nerve injury-induced microgliosis and astrocyte activation in the spinal cord and restored the physiological levels of proinflammatory and anti-inflammatory cytokines in periphery and in spinal cord. CONCLUSION AND IMPLICATIONS: The prokineticin system contributes to pain modulation via neuron-glia interaction. Sustained inhibition of the prokineticin system, at peripheral or central levels, blocked both pain symptoms and some events underlying disease progression.


Asunto(s)
Hormonas Gastrointestinales/metabolismo , Hiperalgesia/metabolismo , Neuralgia/metabolismo , Neuropéptidos/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Animales , Ganglios Espinales/metabolismo , Hormonas Gastrointestinales/genética , Hiperalgesia/tratamiento farmacológico , Interleucina-10/genética , Interleucina-10/metabolismo , Interleucina-1beta/genética , Interleucina-1beta/metabolismo , Masculino , Ratones , Neuralgia/tratamiento farmacológico , Neuroglía/metabolismo , Neuropéptidos/genética , ARN Mensajero/metabolismo , Receptores Acoplados a Proteínas G/antagonistas & inhibidores , Receptores Acoplados a Proteínas G/genética , Nervio Ciático/metabolismo , Médula Espinal/metabolismo
11.
Glia ; 62(1): 122-32, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24272707

RESUMEN

The purinergic system is highly involved in the regulation of microglial physiological processes. In addition to the accepted roles for the P2 X4,7 and P2 Y12 receptors activated by adenosine triphosphate (ATP) and adenosine diphosphate, respectively, recent evidence suggests a role for the adenosine A2A receptor in microglial cytoskeletal rearrangements. However, the expression and function of adenosine A1 receptor (A1AR) in microglia is still unclear. Several reports have demonstrated possible expression of A1AR in microglia, but a new study has refuted such evidence. In this study, we investigated the presence and function of A1AR in microglia using biomolecular techniques, live microscopy, live calcium imaging, and in vivo electrophysiological approaches. The aim of this study was to clarify the expression of A1AR in microglia and to highlight its possible roles. We found that microglia express A1AR and that it is highly upregulated upon ATP treatment. Moreover, we observed that selective stimulation of A1AR inhibits the morphological activation of microglia, possibly by suppressing the Ca(2+) influx induced by ATP treatment. Finally, we recorded the spontaneous and evoked activity of spinal nociceptive-specific neuron before and after application of resting or ATP-treated microglia, with or without preincubation with a selective A1AR agonist. We found that the microglial cells, pretreated with the A1AR agonist, exhibit lower capability to facilitate the nociceptive neurons, as compared with the cells treated with ATP alone.


Asunto(s)
Microglía/fisiología , Receptor de Adenosina A1/metabolismo , Potenciales de Acción/efectos de los fármacos , Adenosina Trifosfato/farmacología , Animales , Animales Recién Nacidos , Calcio/metabolismo , Células Cultivadas , Lipopolisacáridos/farmacología , Ratones , Microglía/efectos de los fármacos , Agonistas del Receptor Purinérgico P1/farmacología , Antagonistas de Receptores Purinérgicos P1/farmacología , ARN Mensajero/metabolismo , ARN Interferente Pequeño/metabolismo , Receptor de Adenosina A1/genética , Médula Espinal/citología , Médula Espinal/metabolismo
12.
Br J Pharmacol ; 171(10): 2621-30, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24308803

RESUMEN

BACKGROUND AND PURPOSE: Osteoporosis is a condition characterized by a decrease in bone density, which decreases its strength and results in fragile bones. The endocannabinoid/endovanilloid system has been shown to be involved in the regulation of skeletal remodelling. The aim of this study was to investigate the possible modulation of bone mass mediated by the transient receptor potential vanilloid type 1 channel (TRPV1) in vivo and in vitro. EXPERIMENTAL APPROACH: A multidisciplinary approach, including biomolecular, biochemical and morphological analysis, was used to investigate the involvement of TRPV1 in changes in bone density in vivo and osteoclast activity in vitro, in wild-type and Trpv1(-/-) mice, that had undergone ovariectomy or had a sham operation. KEY RESULTS: Genetic deletion of Trpv1 as well as pharmacological inhibition/desensitization of TRPV1 signalling dramatically reduced the osteoclast activity in vitro and prevented the ovariectomy-induced bone loss in vivo, whereas the expression of cannabinoid type 2 (CB2 ) receptors was increased. CONCLUSIONS AND IMPLICATIONS: These findings highlight the pivotal role TRPV1 channels play in bone resorption and suggest a possible cross-talk between TRPV1 and CB2 receptors. Based on these results, hybrid compounds acting on both TRPV1 and CB2 receptors in an opposite manner could provide a future pharmacological tool for the treatment of diseases associated with disturbances in the bone remodelling process.


Asunto(s)
Conservadores de la Densidad Ósea/farmacología , Remodelación Ósea/efectos de los fármacos , Capsaicina/análogos & derivados , Osteoclastos/efectos de los fármacos , Osteoporosis Posmenopáusica/prevención & control , Ovariectomía , Transducción de Señal/efectos de los fármacos , Canales Catiónicos TRPV/antagonistas & inhibidores , Canales Catiónicos TRPV/deficiencia , Animales , Densidad Ósea/efectos de los fármacos , Capsaicina/farmacología , Células Cultivadas , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Ratones Endogámicos C57BL , Ratones Noqueados , Osteoclastos/metabolismo , Osteoporosis Posmenopáusica/genética , Osteoporosis Posmenopáusica/metabolismo , Receptor Cross-Talk , Receptor Cannabinoide CB2/efectos de los fármacos , Receptor Cannabinoide CB2/metabolismo , Canales Catiónicos TRPV/genética
13.
Plant Dis ; 98(11): 1582, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30699796

RESUMEN

The genus Viburnum comprises over 150 species of shrubs and small trees such as Laurustinus (Viburnum tinus L.), which is one of the most widely used ornamental plants in private and public gardens. Furthermore, it commonly forms stands of natural woodland in the Mediterranean area. In autumn 2012, a survey was conducted to determine the presence of Phytophthora ramorum on Viburnum in commercial nurseries in the Latium region where wilting, dieback, and death of twigs were observed on 30% of the Laurustinus plants. A Phytophthora species was consistently recovered from soil rich in feeder roots from potted Laurustinus plants showing symptoms. Soil samples were baited with rhododendron leaves. Small pieces of leaf tissue cut from the margin of lesions were plated on P5ARPH selective medium (4). Pure cultures, obtained by single-hypha transfers on potato dextrose agar (PDA), were petaloid. Sporangia formation was induced on pepper seeds (3). Sporangia were almost spherical, ovoid or obpyriform, non-papillate and non-caducous, measuring 36.6 to 71.4 × 33.4 to 48.3 µm (average 53.3 × 37.4 µm) with a length/width ratio of 1.4. Chlamydospores were terminal and 25.2 to 37.9 µm in diameter. Isolates were considered heterothallic because they did not produce gametangia in culture or on the host. All isolates examined had 30 to 35°C as optimum temperatures. Based on these morphological characteristics, the isolates were identified as Phytophthora hydropathica (2). Morphological identification was confirmed by internal transcribed spacer (ITS), and mitochondrial partial cytochrome oxidase subunit 2 (CoxII) with BLAST analysis in the NCBI database revealing 99% identity with ITS and 100% identity with CoxII. The sequences of the three isolates AB234, AB235, and AB236 were deposited in European Nucleotide Archive (ENA) with the accession nos. HG934148, HG934149, and HG934150 for ITS and HG934151, HG934152, and HG934153 for CoxII, respectively. Pathogenicity tests were conducted in the greenhouse on a total of six 1-year-old shoots cut from V. tinus plants with two inoculation points each. Mycelial plugs cut from the margins of actively growing 8-day-old cultures on PDA were inserted through the epidermis into the phloem. Controls were treated as described above except that sterile PDA plugs replaced the inoculum. Shoots were incubated in test tubes with sterile water in the dark at 24 ± 2°C. After 2 weeks, lesions were evident at the inoculation points and symptoms were similar to those caused by natural infection. P. hydropathica was consistently re-isolated from the margin of lesions, while controls remained symptomless. In the United States in 2008, P. hydropathica was described as spreading from irrigation water to Rhododendron catawbiense and Kalmia latifolia (2). This pathogen can also attack several other horticultural crops (1), but to our knowledge, this is the first report of P. hydropathica causing wilting and shoot dieback on V. tinus. References: (1) C. X. Hong et al. Plant Dis. 92:1201, 2008. (2) C. X. Hong et al. Plant Pathol. 59:913, 2010. (3) E. Ilieva et al. Eur. J. Plant Path. 101:623, 1995. (4) S. N. Jeffers and S. B. Martin. Plant Dis. 70:1038, 1986.

14.
Plant Dis ; 97(10): 1385, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30722173

RESUMEN

The genus Rhododendron comprises over 1,000 species, which represent many important ornamental shrubs. Microbial isolations were made from Rhododendron catawbiense plants showing symptoms of wilt, dieback, and death of shoots obtained from two nurseries in the Latium region in the late summer of 2012. A Phytophthora species was consistently recovered by plating small pieces of stem and collar tissues, cut from the margin of lesions, on P5ARPH selective medium. Pure cultures were obtained by single-hyphal transfers and they grew in a rosaceous pattern on potato dextrose agar (PDA) at an optimum temperature of 28 to 30°C. Sporangia formation was induced on pepper seeds (3). Sporangia were ellipsoid, fusiform or obpyriform, papillate, occasionally bipapillate, caducous, with a long pedicel (up to 100 µm), and mean dimensions of 45 × 25 µm with a mean length/width ratio of 1.8. Chlamydospores ranged from 25 to 32 µm in diameter. Isolates were considered heterothallic because they did not produce gametangia in vitro or in planta. On the basis of morphological features, the isolates were identified as Phytophthora tropicalis Aragaki & Uchida. Identity was confirmed by sequence comparison in GenBank with 99% homology both for internal transcribed spacer (ITS) and mitochondrial partial COI for cytochrome oxidase subunit 1. The sequences of two isolates AB211 and AB212 were deposited in the European Nucleotide Archive (ENA) with accession nos. HF937577 and HF937578 for ITS, and HF937579 and HF937580 for COI, respectively. Pathogenicity tests were conducted in the greenhouse on a total of six 1-year-old shoots cut from R. catawbiense plants with two inoculation points each. Mycelial plugs cut from the margins of actively growing 8-day-old cultures on PDA were inserted through the epidermis to the phloem. Controls were treated as described above except for inoculation with sterile PDA plugs. Inoculated shoots were incubated in test tubes with sterile water for 1 week in the dark at 26 ± 2°C. Lesions were evident at the inoculation points. P. tropicalis was consistently reisolated from the margin of symptomatic tissues. Control shoots remained symptomless. In Italy, P. tropicalis has been reported on several ornamental species (1) and on apricot trees (4) indicating a broad host range. On the same host it has been reported in Virginia, United States (2). To the best of our knowledge, this is the first report of Phytophthora damage on Rhododendron caused by P. tropicalis in Italy. References: (1) S. O. Cacciola et al. Plant Dis. 90: 680, 2006. (2) C. X. Hong et al. Plant Dis. 90: 525, 2006. (3) E. Ilieva et al. Eur. J. Plant Path. 101: 623, 1995. (4) A. Pane et al. Plant Dis. 93: 844, 2009.

15.
Plant Dis ; 96(11): 1695, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30727500

RESUMEN

Common walnut (Juglans regia L.) is an important nut crop in Italy, which is the fifth largest producer of walnut in Europe. In recent years, walnut decline and subsequent death has increased in many Italian commercial orchards. In the summer of 2010, several declining trees were present in waterlogged area of a walnut orchard located in the Veneto region. Symptoms included sparse foliage, wilting, and shoot and branch dieback. By the next year, a larger area of about 1 ha with 20% of dead trees was present, and soil/root samples were subjected to azalea leaf baiting and successively cultured on PARBH medium (3). Isolates were identified as Phytophthora megasperma based on morphological characteristics (2) and DNA sequence analysis. Sporangia were 35.0 to 62.0 × 12.0 to 30.0 µm, nonpapillate, and noncaducous when produced in soil extract solution. Oogonia had an average diameter of 36 µm with mostly paragynous antheridia. Identity was confirmed by sequence comparison in NCBI database with 99% and 100% identity for internal transcribed spacer (ITS) and mitochondrial partial COI (4) for cytochrome oxidase subunit 1, respectively. The sequences of the isolate AB199 were deposited in GenBank with the accession nos. HE805270 and HE805269 for ITS and COI, respectively. Pathogenicity tests were conducted in the greenhouse on six 1-year-old walnut shoots with two inoculation points each. Mycelial plugs cut from the margins of actively growing 8-day-old cultures on PDA were inserted through the epidermis to the phloem. Controls were treated as described above except for inoculation with sterile PDA plugs. After inoculation, shoots were incubated in test tubes with sterile water for 1 week in the dark at 22 ± 2°C. Lesions were evident at the inoculation points. P. megasperma was consistently reisolated from the margin of symptomatic tissues. Controls remained symptomless. P. megasperma is a polyphagous, ubiquitarious Phytophthora species that attacks many crops and fruit species including walnut. Although several other species of Phytophthora have been reported from Italy (1), to the best of our knowledge, this is the first report of Phytophthora decline on common walnut in Italy caused by P. megasperma. References: (1) A. Belisario et al. Acta Hort. 705:401, 2006. (2) D. C. Erwin and O. K. Ribeiro. Phytophthora Diseases Worldwide. The American Phytopathological Society, St. Paul, MN, 1996. (3) G. C. Papavisas et al. Phytopathology 71:129, 1981. (4) G. P. Robideau et al. Mol. Ecol. Resour. 11:1002, 2011.

16.
J Biotechnol ; 159(4): 251-64, 2012 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-21884735

RESUMEN

Juglans nigra and Juglans regia are two highly economically important species for wood and fruit production that are susceptible to anthracnose caused by Gnomonia leptostyla. The identification of genotypes resistant to anthracnose could represent a valid alternative to agronomic and chemical management. In this study, we analyzed 72 walnut genotypes that showed a variety of resistance phenotypes in response to natural infection. According to the disease severity rating and microsatellite fingerprinting analysis, these genotypes were divided into three main groups: (40) J. nigra resistant, (1) J. nigra susceptible, and (31) J. regia susceptible. Data on leaf emergence rates and analysis of in vivo pathogenicity indicated that the incidence of anthracnose disease in the field might be partially conditioned by two key factors: the age and/or availability of susceptible leaves during the primary infection of fungus (avoidance by late flushing) and partial host resistance. NBS profiling approach, based on PCR amplification with an adapter primer for an adapter matching a restriction enzyme site and a degenerate primer targeting the conserved motifs present in the NBS domain of NBS-LRR genes, was applied. The results revealed the presence of a candidate marker that correlated to a reduction in anthracnose incidence in 72 walnut genotypes.


Asunto(s)
Colletotrichum/fisiología , Juglans , Enfermedades de las Plantas/microbiología , Análisis por Conglomerados , ADN de Plantas/análisis , ADN de Plantas/aislamiento & purificación , Resistencia a la Enfermedad , Genotipo , Interacciones Huésped-Patógeno , Repeticiones de Microsatélite , Técnicas de Amplificación de Ácido Nucleico , Fenotipo , Hojas de la Planta/química , Hojas de la Planta/crecimiento & desarrollo , Hojas de la Planta/microbiología , Estadísticas no Paramétricas
17.
Br J Pharmacol ; 166(3): 950-63, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22122547

RESUMEN

BACKGROUND AND PURPOSE: The amphibian peptide Bv8 induces potent nociceptive sensitization in rodents. Its mammalian homologue, prokineticin 2 (PROK2), is strongly up-regulated in inflamed tissues and is a major determinant in triggering inflammatory pain. Bv8 and PROK2 activate two closely related GPCRs, PK(1) and PK(2) , in a relatively non-selective fashion. To characterize better the roles of the two receptors in hyperalgesia and to obtain ligands whose binding affinity and efficacy differed for the two receptors, we modified the Bv8 molecule in regions essential for receptor recognition and activation. EXPERIMENTAL APPROACH: We modified the Bv8 molecule by substituting Trp in position 24 with Ala (A-24) and compared it with Bv8 for binding and activating PK(1) and PK(2) receptors in cell preparations and in affecting nociceptive thresholds in rodents. KEY RESULTS: A-24 preferentially bound to PK(2) receptors and activated them with a lower potency (5-fold) than Bv8. When systemically injected, A-24 induced Bv8-like hyperalgesia in rats and in mice, at doses 100 times higher than Bv8. Locally and systemically injected at inactive doses, A-24 antagonized Bv8-induced hyperalgesia. In rat and mouse models of inflammatory and post-surgical pain, A-24 showed potent and long-lasting anti-hyperalgesic activity. Unlike Bv8, A-24 increased ß-endorphin levels in mouse brain. CONCLUSIONS AND IMPLICATIONS: A-24 induced its anti-hyperalgesic effect in rodents by directly blocking nociceptor PK(1) receptors and by activating the central opioid system and the descending pain control pathway through brain PK(2) receptors.


Asunto(s)
Proteínas Anfibias/química , Proteínas Anfibias/farmacología , Analgésicos/química , Analgésicos/farmacología , Neuropéptidos/química , Neuropéptidos/farmacología , Receptores Acoplados a Proteínas G/metabolismo , Receptores de Péptidos/metabolismo , Alanina/química , Sustitución de Aminoácidos , Proteínas Anfibias/uso terapéutico , Analgésicos/uso terapéutico , Animales , Células CHO , Quimiotaxis/efectos de los fármacos , Cricetinae , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Edema/tratamiento farmacológico , Hiperalgesia/tratamiento farmacológico , Hiperalgesia/metabolismo , Ligandos , Macrófagos/citología , Macrófagos/efectos de los fármacos , Masculino , Ratones , Neuropéptidos/uso terapéutico , Dolor Postoperatorio/tratamiento farmacológico , Dolor Postoperatorio/metabolismo , Unión Proteica , Ratas , Ratas Sprague-Dawley , Relación Estructura-Actividad , Transfección , Triptófano/química
18.
Phytopathology ; 101(6): 679-86, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21261470

RESUMEN

Fusarium lateritium is a globally distributed plant pathogen. It was recently reported as the causal agent of nut gray necrosis (NGN) on hazelnut. Isolate characterization within F. lateritium was undertaken to investigate how morphological and molecular diversity was associated with host and geographic origin. Morphological studies combined with inter-simple-sequence repeat (ISSR) analysis, and phylogenetic analyses using translation elongation factor 1α (TEF-1α), ß-tubulin genes, and nuclear ribosomal DNA internal transcribed spacer (ITS) sequences were conducted to resolve relationships among 32 F. lateritium isolates from NGN-affected hazelnut fruit, and 14 from other substrates or 8 from other hosts than hazelnut. Colonies of F. lateritium from hazelnut showed dark grayish-olive differing from the orange-yellow color of all other isolates from other hosts. Generally, isolates from NGN-affected fruit failed to produce sporodochia on carnation leaf agar. The influence of host and substrate on the genetic structure of F. lateritium was supported by ISSR and analyzed with principal coordinates analysis. A relationship between hazelnut and genetic variation was inferred. Phylogenetic analysis of ITS provided limited resolution while TEF-1α and ß-tubulin analyses allowed a clear separation between the European and non-European F. lateritium isolates retrieved from GenBank, regardless of host. Though morphological traits of F. lateritium isolates from hazelnut were generally uniform in defining a typical morphogroup, they were not yet phylogenetically defined. In contrast, the typology related to slimy deep orange cultures, due to spore mass, grouped clearly separated from the other F. lateritium isolates and revealed a congruence between morphology and phylogeny.


Asunto(s)
Corylus/microbiología , Fusarium/clasificación , Fusarium/genética , Variación Genética , Enfermedades de las Plantas/microbiología , Secuencia de Bases , ADN de Hongos/química , ADN de Hongos/genética , ADN Espaciador Ribosómico/química , ADN Espaciador Ribosómico/genética , Frutas/microbiología , Fusarium/aislamiento & purificación , Fusarium/patogenicidad , Italia , Repeticiones de Minisatélite/genética , Datos de Secuencia Molecular , Factor 1 de Elongación Peptídica/genética , Fenotipo , Filogenia , Reacción en Cadena de la Polimerasa , Análisis de Secuencia de ADN , Especificidad de la Especie , Tubulina (Proteína)/química , Tubulina (Proteína)/genética
19.
Neurobiol Dis ; 37(1): 177-85, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19804829

RESUMEN

Neuropathic pain is a devastating neurological disease that seriously affects quality of life in patients. The mechanisms leading to the development and maintenance of neuropathic pain are still poorly understood. However, recent evidence points towards a role of spinal microglia in the modulation of neuronal mechanisms. In this context, cannabinoids are thought to modulate synaptic plasticity as well as glial functions. Here, we have investigated the effect of chronic treatment with a selective agonist of cannabinoid type 2 receptor (CB2), 1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3 carboxamide (NESS400), on pain thresholds in the spared nerve injury (SNI) model in the mouse and on the distribution and activation of spinal microglia. Repeated treatment with NESS400 (4 mg/kg) significantly alleviated neuropathic mechanical allodynia and thermal hyperalgesia. In the dorsal horn (L4-L6) of neuropathic mice microglia activation (quantification of the length of microglial processes) and astrocytosis were associated with CB2 receptor over-expression on both cell types. Treatment with NESS400 significantly reduced the number of hypertrophic microglia while leaving microglial cell number unaffected and reduced astrogliosis. Moreover, prolonged administration of NESS400 reduced mRNA expression of pro-inflammatory markers and enhanced anti-inflammatory marker gene expression in dorsal horn extracts. In conclusion, we show that selective CB2 receptor stimulation prevents thermal hyperalgesia, alleviates mechanical allodynia and facilitates the proliferation of anti-inflammatory microglial phenotype in the ipsilateral dorsal horn of the spinal cord in SNI mice.


Asunto(s)
Analgésicos/farmacología , Indenos/farmacología , Microglía/efectos de los fármacos , Dolor/tratamiento farmacológico , Pirazoles/farmacología , Receptor Cannabinoide CB2/agonistas , Traumatismos del Sistema Nervioso/tratamiento farmacológico , Animales , Astrocitos/efectos de los fármacos , Astrocitos/fisiología , Recuento de Células , Citocinas/metabolismo , Gliosis/tratamiento farmacológico , Gliosis/fisiopatología , Hiperalgesia/tratamiento farmacológico , Hiperalgesia/fisiopatología , Masculino , Ratones , Ratones Endogámicos C57BL , Microglía/fisiología , Dolor/fisiopatología , Umbral del Dolor/efectos de los fármacos , Estimulación Física , ARN Mensajero/metabolismo , Médula Espinal/efectos de los fármacos , Médula Espinal/fisiopatología , Temperatura , Factores de Tiempo , Traumatismos del Sistema Nervioso/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...